SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

14 май 2024 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

07 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

24 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

13 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

06 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

28 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

08 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

01 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

31 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

19 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

05 сен 2023 08:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

10 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

03 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

01 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 июл 2023 08:00:01 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

23 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Healthcare Conference

31 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

10 май 2023 16:01:00 Источник Nasdaq GlobeNewswire